These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

259 related articles for article (PubMed ID: 15866437)

  • 1. Ropinirole in a child with attention-deficit hyperactivity disorder and restless legs syndrome.
    Konofal E; Arnulf I; Lecendreux M; Mouren MC
    Pediatr Neurol; 2005 May; 32(5):350-1. PubMed ID: 15866437
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Does Restless Legs Syndrome increase cardiovascular risk in Attention-Deficit/Hyperactivity Disorder?
    Angriman M; Bruni O; Cortese S
    Med Hypotheses; 2013 Jan; 80(1):39-42. PubMed ID: 23111202
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Ropinirole: new indication. Restless legs: disproportionate adverse effects.
    Prescrire Int; 2006 Oct; 15(85):173-6. PubMed ID: 17128523
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Ropinirole in restless leg syndrome.
    Ahmed I
    Mo Med; 2002; 99(9):500-1. PubMed ID: 12462942
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Ropinirole in the treatment of restless legs syndrome.
    Kakar RS; Kushida CA
    Expert Rev Neurother; 2005 Jan; 5(1):35-42. PubMed ID: 15853472
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Ropinirole treatment for restless legs syndrome.
    Bogan RK
    Expert Opin Pharmacother; 2008 Mar; 9(4):611-23. PubMed ID: 18312162
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Ropinirole-induced symptomatic sinus node dysfunction.
    Szymanski C; Boey S; Hermida JS
    Pacing Clin Electrophysiol; 2008 Aug; 31(8):1079-82. PubMed ID: 18684270
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The Effect of Atomoxetin Use in the Treatment of Attention-Deficit/Hyperactivity Disorder on the Symptoms of Restless Legs Syndrome: A Case Report.
    Baykal S; Karakurt MN
    Clin Neuropharmacol; 2017; 40(2):93-94. PubMed ID: 28195837
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Ropinirole treatment of restless legs].
    Kinge E; Lossius MI; Mowincel P
    Ugeskr Laeger; 2005 Mar; 167(11):1284-6. PubMed ID: 15830500
    [No Abstract]   [Full Text] [Related]  

  • 10. Restless legs syndrome and attention-deficit/hyperactivity disorder.
    Konofal E; Cortese S
    Ann Neurol; 2005 Aug; 58(2):341-2; author reply 342. PubMed ID: 16049930
    [No Abstract]   [Full Text] [Related]  

  • 11. Effectiveness of ropinirole for RLS and depressive symptoms in an 11-year-old girl.
    Cortese S; Konofal E; Lecendreux M
    Sleep Med; 2009 Feb; 10(2):259-61. PubMed ID: 18291718
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Attention-deficit/hyperactivity disorder and sleep disorders in children.
    Tsai MH; Huang YS
    Med Clin North Am; 2010 May; 94(3):615-32. PubMed ID: 20451036
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Ropinirole (Requip) for restless legs syndrome.
    Med Lett Drugs Ther; 2005 Aug; 47(1214):62-4. PubMed ID: 16052162
    [No Abstract]   [Full Text] [Related]  

  • 14. [The efficacy of ropinirole in the treatment of chronic insomnia secondary to restless legs syndrome: polysomnography data].
    Estivill E; de la Fuente V
    Rev Neurol; 1999 Nov 1-15; 29(9):805-7. PubMed ID: 10696651
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Periodic limb movement disorder and restless legs syndrome in children with attention-deficit hyperactivity disorder.
    Picchietti DL; England SJ; Walters AS; Willis K; Verrico T
    J Child Neurol; 1998 Dec; 13(12):588-94. PubMed ID: 9881529
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Efficacy and tolerability of ropinirole in patients with restless legs syndrome and a baseline IRLS total score > or = 24 points--data from the ropinirole clinical trial programme.
    Giorgi L; Ritchie SY; Kirsch JM
    Curr Med Res Opin; 2006 Oct; 22(10):1867-77. PubMed ID: 17022844
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Ropinirole (Requip) for restless legs syndrome.
    Obstet Gynecol; 2006 Jan; 107(1):176-8. PubMed ID: 16394057
    [No Abstract]   [Full Text] [Related]  

  • 18. Ropinirole is effective in the long-term management of restless legs syndrome: a randomized controlled trial.
    Montplaisir J; Karrasch J; Haan J; Volc D
    Mov Disord; 2006 Oct; 21(10):1627-35. PubMed ID: 16874755
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Obtaining a detailed family history for attention-deficit hyperactivity disorder is important.
    O'Brien LM; Gozal D
    Paediatr Respir Rev; 2002 Mar; 3(1):90, 93. PubMed ID: 12123224
    [No Abstract]   [Full Text] [Related]  

  • 20. An exploratory retrospective evaluation of ropinirole-associated psychotic symptoms in an outpatient population treated for restless legs syndrome or Parkinson's disease.
    Stoner SC; Dahmen MM; Makos M; Lea JW; Carver LJ; Rasu RS
    Ann Pharmacother; 2009 Sep; 43(9):1426-32. PubMed ID: 19690226
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.